Skip to content

Julie Rubinstein, President and COO at Adaptive Biotechnologies, sold ADPT on Oct 14, 2026

Data as of Oct 16

▼ SELL$173K6,781 shares at $25.57Julie Rubinstein President and COOADPT Adaptive Biotechnologies Corp
Watch ADPT
Traded
Oct 14, 2026
Disclosed
Oct 16, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Julie Rubinstein, President and COO at Adaptive Biotechnologies, sold ADPT on Oct 14, 2026TRADEDDISCLOSED
ADPTSimilar stocks (XLV — its sector index fund), rebased to ADPT's price on the disclosure day
ADPT since disclosure
0.0%
after the sale
Similar stocks (XLV) since disclosure
0.0%
XLV — its sector index fund

Change in closing price from Oct 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$7.6Kdisclosed Oct 16 · filed the same day
  2. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$280Kdisclosed Oct 16 · filed the same day
  3. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$304Kdisclosed Oct 16 · filed 1 day after the trade
  4. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$132Kdisclosed Oct 16 · filed 2 days after the trade

See every trade on ADPT →